Latest Europe News

Dimerix has secured full sponsorship of the US Investigational New Drug application for its Phase 2-ready kidney drug DMX-652, setting the stage for a clinical trial targeting acute kidney injury in late 2026.

OncoSil Medical has won FDA Humanitarian Device Exemption approval for its OncoSil™ device to treat distal cholangiocarcinoma, opening a US market estimated at A$80 million annually.

Temas Resources posted a CAD 2.63 million loss for H1 2026, driven by ramped-up exploration and RCL technology development, while securing $1.5 million in fresh funding and signing initial RCL licensing contracts.

Laramide Resources has secured strategic uranium exploration licences in Sweden’s Hotagen and Arjeplog-Arvidsjaur provinces, capitalising on the country’s recent policy reversal to permit uranium mining.

Marlin Global delivered a robust 3.1% gross portfolio return in July 2026, significantly outpacing its benchmark which fell 3.6%, thanks to strategic semiconductor underweighting and strong gains in tech giants Microsoft, Dexcom, and Amazon.

The WCM Quality Global Growth Fund posted a -5.20% return in July 2026, underperforming its MSCI benchmark as semiconductor stocks faltered. Despite short-term setbacks, the fund maintains strong long-term outperformance and is increasing exposure to AI-related companies.

Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.

EAU Lithium, a subsidiary of Cosmos Exploration, has signed a strategic Master Services Agreement with VULTEC, the German technology arm of Vulcan Energy Resources, to advance lithium extraction projects in Bolivia using cutting-edge direct lithium extraction technology.

EcoGraf has secured a binding term sheet with a major German graphite trader to double its Epanko graphite offtake to 40,000 tpa after five years, underpinning future expansions and project financing.

KTEK Aerosystems has obtained a key export licence from the Netherlands, enabling it to ship components to its US facility for assembly and delivery. This milestone solidifies the company’s trans-Atlantic supply chain and supports its targeted September delivery restart.

Bravura Solutions posted a 49% rise in net profit after tax for FY26 despite a near 10% decline in revenue, supported by strong margin improvements and underlying profit growth. The company declared a 15 cent final dividend, secured a $100 million debt facility, and announced a $50 million share buyback.

Anteris Technologies posted a $51.7 million loss in H1 2026 amid ramped-up R&D and clinical trial activity, supported by a $320 million capital raise and Medicare reimbursement for its DurAVR heart valve trial.